Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
281 studies found for:    Thrombocytopenia: Clinical Trials
Show Display Options
Download search resultsDownload the search results for:
Thrombocytopenia: Clinical Trials (281 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: recombinant human thrombopoietin
2 Unknown  The HIT-TRAP Trial
Condition: Heparin-Induced Thrombocytopenia
Intervention: Drug: Standard heparin (UFH) versus certoparin (LMWH)
3 Unknown  A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
Conditions: Alloimmune Thrombocytopenia;   Fetal Alloimmune Thrombocytopenia
Intervention: Drug: IVIG (Intravenous Immunoglobulin)
4 Recruiting American Trial Using Tranexamic Acid in Thrombocytopenia
Condition: Thrombocytopenia
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
5 Completed WEUSKOP5410: Observational Study in ENABLE Clinical Trials
Condition: Hepatitis C
Intervention: Drug: eltrombopag
6 Completed
Has Results
A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma
Conditions: Chemotherapy-Induced Thrombocytopenia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Cancer;   Oncology;   Thrombocytopenia
Intervention: Biological: AMG 531
7 Recruiting Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
Conditions: Antineoplastic Adverse Reaction;   Thrombocytopenia;   Acute Myelocytic Leukemia
Intervention: Drug: rhTPO
8 Recruiting Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy
Conditions: Immune Thrombocytopenia;   Pregnancy
Intervention: Drug: rhTPO
9 Completed
Has Results
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Chemotherapy-Induced Thrombocytopenia;   Non-Small Cell Lung Cancer;   Cancer;   Lung Neoplasms;   Oncology;   Solid Tumors;   Thrombocytopenia
Interventions: Biological: Romiplostim;   Drug: Placebo;   Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Cisplatin
10 Recruiting Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients
Condition: Thrombocytopenia
Intervention: Drug: recombinant human thrombopoietin
11 Terminated A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura)
Condition: Idiopathic Thrombocytopenic Purpura
Interventions: Drug: Eltrombopag;   Drug: Avatrombopag
12 Completed Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
Condition: Heparin-Induced Thrombocytopenia
Intervention: Drug: argatroban
13 Recruiting Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
Conditions: Chronic Liver Disease;   Thrombocytopenia
Interventions: Drug: Lusutrombopag;   Drug: Placebo
14 Terminated A Study to Investigate the Efficacy and Safety of S-888711 Tablets Administered to Adult Subjects With Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia (ITP)
Interventions: Drug: placebo to S-888711;   Drug: S-888711
15 Unknown  Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia
Condition: Non-Hodgkin Lymphoma
Intervention: Drug: Romiplostim
16 Completed An Open-label Safety Study of S-888711
Condition: Immune Thrombocytopenia
Intervention: Drug: 0.5 mg of S-888711
17 Withdrawn The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention:
18 Recruiting Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Interventions: Drug: Romiplostim;   Drug: Placebo
19 Not yet recruiting Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia
Conditions: Adult Immune Thrombocytopenia (ITP);   Dapsone
Interventions: Drug: Dapsone (Disulone®);   Drug: Prednisone (Cortancyl®) alone followed by monitoring and "standard of care";   Drug: Prednisone (Cortancyl®)
20 Completed An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: Human immunoglobulin intravenous

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.